Navigation Links
Arizona Pain Specialists Contend Recent Vertebroplasty Studies are Misleading
Date:8/7/2009

SCOTTSDALE, Ariz., Aug. 7 /PRNewswire/ -- Two studies released August 6, 2009 in the New England Journal of Medicine claim to demonstrate that vertebroplasty, a procedure to treat some painful spine fractures, is not effective. According to several authorities in the field, this is incorrect, as both studies actually demonstrate a significant improvement in patients' pain and ability to function normally.

Tory McJunkin, MD, co-founder of Arizona Pain Specialists, has a personal connection because his grandmother recently had the procedure performed with a life-changing, pain-relieving outcome. Dr. McJunkin explained that "Clinical data show that this procedure relieves pain and improves patients' quality of life. I have seen amazing results from vertebroplasty in my practice and for my grandmother."

Allen Burton, MD, Professor of Anesthesiology at MD Anderson in Houston, one of the foremost experts on vertebroplasty, stated, "The conclusion that vertebroplasty does not help back pain is completely wrong. If you look closely at the study design, what they are calling a placebo is actually a facet injection."

"These studies actually show that both treatments are effective," said Paul Lynch, MD, co-founder of Arizona Pain Specialists. "The studies did not use a true control group condition, where patients would receive no treatment. The 'control' patients actually received a different effective treatment and both groups demonstrated highly clinically significant reductions in pain. This demonstrates that vertebroplasty is an effective procedure, although facet injections are also effective."

Pain is often measured on a 0 to 10 scale, with higher numbers indicating greater pain. The studies demonstrate that patients who received the vertebroplasty procedure had reductions in pain of 2.3 and 3.0 points in the two studies, compared to reductions o
'/>"/>

SOURCE Arizona Pain Specialists
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. The University of Arizona College of Medicine and OmegaGenesis Announce Collaboration Agreement to Address Diabetic Foot Ulcers
2. Arizona Heart Innovative Technologies Licenses New Endovascular Device
3. Arizona Heart Institute First to Implant Powerlink XL in Phoenix, Arizona Since FDA Approval
4. First Annual Arizona Biotech Day Announced for October 23rd 2008
5. ThirdBiotech Launches Research Institute to Promote Formation and Growth of Arizona-Based Biotech Companies
6. Arizona-Based SenesTech, Inc., Partners With Australia to Stop Starvation Due to Rice Shortages
7. VAP Cholesterol Test From Atherotech Covers 90 Percent of Arizona Insured
8. Arizona Pain Society and Dr. Robert Barkin, Rush University Medical Center, Present Program on Comprehensive Urine Drug Testing Sponsored by Dominion Diagnostics
9. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
10. West Penn Allegheny Health System Announces Recruitment of Leading Burn Specialists
11. Unique New Initiative by World-Recognized Specialists in Heart Disease and Diabetes to Reduce Residual Vascular Risk Launched Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Research and Markets  has announced the addition of the ... Report" report to their offering. This ... (SOFCs) in US$ Thousands. The report provides separate comprehensive analytics ... Europe , Asia-Pacific , and Rest ... period 2012 through 2020. Market data and analytics are derived ...
(Date:8/19/2014)... 19, 2014 In November 2012, the European ... Evaluation Report (PBRER) in a new PSUR – responding to ... benefit-risk profile of a drug. Adopted in many regions, the ... Present a comprehensive and critical analysis of new or ... Highlight any new evidence of the potential benefits of ...
(Date:8/18/2014)... A new therapy developed by researchers at the ... Medicine and Columbia University Medical Center (CUMC) may ... disease treatment. , The researchers demonstrated in ... could selectively inhibit blood vessel re-narrowing and simultaneously ... a balloon catheter to open narrowed or blocked ...
(Date:8/18/2014)... Global HIV Infection Drug Market and Pipeline Insight ... of HIV infection and the number of deaths due to ... rate across the globe. It has been estimated that the ... in 2013, with the rates for children being even much ... infection rates has been the improved access to antiretroviral drugs ...
Breaking Biology Technology:Global Solid Oxide Fuel Cells (SOFCs) - Strategic Business Report 2014 2Top Five Best Practices for Developing Your Periodic Benefit Risk Evaluation Report (PBRER), New Webinar Hosted by Xtalks 2Selective therapy may improve artery repair after interventional cardiovascular procedures 2Selective therapy may improve artery repair after interventional cardiovascular procedures 3Global HIV Infection Drug Market Overview 2Global HIV Infection Drug Market Overview 3Global HIV Infection Drug Market Overview 4
... Hospitals in Western Pennsylvania Earn Designation, PITTSBURGH, ... named Allegheny General Hospital, UPMC Presbyterian Shadyside and ... Rare Cancers., Complex and rare cancers comprise ... making it difficult for patients to locate or,research ...
... has announced,development of a chemically synthesized vaccine specific ... patented Replikins(TM) technology.,When the vaccine was administered orally ... Taura virus. The specificity of the protective,effect was ... active,regions in the vaccine, and as a result ...
... Prescribing of Copaxone over an Interferon-Beta Therapy, According to a ... ... Resources, WALTHAM, Mass., March 11 Decision Resources, one ... issues, finds that Teva Pharmaceutical,s Copaxone has the,greatest patient share among ...
Cached Biology Technology:Highmark Blue Cross Blue Shield and National Association Name Area Hospitals as Blue Distinction Centers for Complex and Rare Cancers 2Highmark Blue Cross Blue Shield and National Association Name Area Hospitals as Blue Distinction Centers for Complex and Rare Cancers 3Replikins Oral Vaccine Synthesized in 7 Days Protects 91% of Shrimp Against a Lethal Virus 2Teva Pharmaceutical's Altered Peptide Ligand Copaxone Boasts the Greatest Patient Share Among First- and Second-Line Therapies for the Treatment of Multiple Sclerosis 2Teva Pharmaceutical's Altered Peptide Ligand Copaxone Boasts the Greatest Patient Share Among First- and Second-Line Therapies for the Treatment of Multiple Sclerosis 3
(Date:8/19/2014)... and tuberculosis live side-by-side. Worldwide there are approximately ... nearly all of them occurring where tuberculosis is ... or BCG, provides only partial protection against both ... is needed to combat both diseases. UCLA-led research ... diseases., In a study published in the September ...
(Date:8/19/2014)... CAMBRIDGE, MA -- MIT chemical engineers have devised a ... that are released slowly over a few weeks. When ... induces the body to rapidly form new bone that ... This type of coated scaffold could offer a dramatic ... which involves transplanting bone from another part of the ...
(Date:8/19/2014)... with neonatal abstinence syndrome (NAS) secondary to in-utero ... through withdrawal than others, but the underlying reasons ... (when genes are turned on or off) changes ... at Boston University School of Medicine (BUSM) and ... its kind study to identify some of these ...
Breaking Biology News(10 mins):New vaccine shows promise as stronger weapon against both tuberculosis and leprosy 2Engineering new bone growth 2Engineering new bone growth 3In-utero methadone, Subutex exposure could alter gene expression, cause severe Neonatal Abstience Syndrome 2
... may help to identify which depressed patients will ... signal, detectable by noninvasive imaging, also holds clues ... for drug development, say National Institutes of Health ... of several such markers, including factors detectable in ...
... pollution and heavy fishingare adding insult to injury in ... by the Wildlife Conservation Society and the University of ... found that pollution and overfishing on reef systems have ... wormsthat further degrade corals, a discovery that underlines the ...
... University of Oklahoma research team has been awarded a five-year, ... that can lead to a greater understanding of human diseases ... infections. The goal of the NIH grant is to ... research in Oklahoma. "This is the first NIH ...
Cached Biology News:Brain signal IDs responders to fast-acting antidepressant 2Brain signal IDs responders to fast-acting antidepressant 3Brain signal IDs responders to fast-acting antidepressant 4Brain signal IDs responders to fast-acting antidepressant 5Brain signal IDs responders to fast-acting antidepressant 6Microbes, sponges, and worms add to coral reef woes 2Microbes, sponges, and worms add to coral reef woes 3OU research group awarded $9.7 million NIH CoBRE grant in structural biology 2
Designed for use with all 96-well SPRI reagent kits. Used with round bottom 96-well microplates, and 96-well thermal cycling plates....
... Polystyrene covers can be ... Ridged covers for stacking ... Non-ridged covers for use with ... covers, ridged and non-ridged, are ...
... can be used with all ... for stacking of covered plates ... use with automated systems ... non-ridged, are available for use ...
... made from an inert polymer with a unique ... 384 split septum caps for use with 384-well ... PCR when used in conjunction with screw or ... standard pipetting equipment 384 septum caps may ...
Biology Products: